280 results
·
18ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)
FDA Pre-Market Approval
FDA Class 3
·Amplia MRI CRT-D/Amplia MRI Quad CRT-D/ Brava CRT-D/Claria Quad CRT-D/ Brava Quad CRT-D/ Compia MRI Quad CRT-D/ Viva Qua
Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
FDA Pre-Market Approval
FDA Class 3
·DIASORIN ETI MAK-2 PLUS ASSAY
System, Test, Alpha-Fetoprotein, Ria
FDA classification
FDA Class 3
·System, Test, Alpha-Fetoprotein, Ria
System, Test, Tumor Marker, For Detection Of Bladder Cancer
FDA Pre-Market Approval
FDA Class 3
·ALERE NMP22 URINE COLLECTION KIT
Stent Graft, Bypass, Superficial Femoral Artery
FDA classification
FDA Class 3
·Stent Graft, Bypass, Superficial Femoral Artery
Stent, Iliac Vein
FDA classification
FDA Class 3
·Stent, Iliac Vein
Stent, Renal
FDA classification
FDA Class 3
·Stent, Renal
Transcatheter Septal Occluder (Ventricular)
FDA classification
FDA Class 3
·Transcatheter Septal Occluder (Ventricular)
Stent, Iliac
FDA classification
FDA Class 3
·Stent, Iliac
Transcatheter Septal Occluder (Atrial)
FDA classification
FDA Class 3
·Transcatheter Septal Occluder (Atrial)
Stent, Carotid
FDA classification
FDA Class 3
·Stent, Carotid
Pulmonary Stent
FDA classification
FDA Class 3
·Pulmonary Stent
Stent, Superficial Femoral Artery
FDA classification
FDA Class 3
·Stent, Superficial Femoral Artery
Absorbable Coronary Drug-Eluting Stent
FDA classification
FDA Class 3
·Absorbable Coronary Drug-Eluting Stent
Extracorporeal Shock Wave Treatment
FDA classification
FDA Class 3
·Extracorporeal Shock Wave Treatment
Coronary Drug-Eluting Stent
FDA classification
FDA Class 3
·Coronary Drug-Eluting Stent
Stent, Superficial Femoral Artery, Drug-Eluting
FDA classification
FDA Class 3
·Stent, Superficial Femoral Artery, Drug-Eluting
Stent, Coronary
FDA classification
FDA Class 3
·Stent, Coronary
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA classification
FDA Class 3
·Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
Immunohistochemistry Antibody Assay, C-Kit
FDA classification
FDA Class 3
·Immunohistochemistry Antibody Assay, C-Kit